![J. Marc Simard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
J. Marc Simard
Directeur/Bestuurslid bij Remedy Pharmaceuticals, Inc.
Profiel
Dr. J.
M.
Simard is on the Board of Directors at Remedy Pharmaceuticals, Inc.
Dr. Simard was previously employed as an Advisory Board Member by Carrot Capital LLC.
He received his undergraduate degree from St. Anselm College and a doctorate degree from Creighton University.
Actieve functies van J. Marc Simard
Bedrijven | Functie | Begin |
---|---|---|
Remedy Pharmaceuticals, Inc.
![]() Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Directeur/Bestuurslid | - |
Eerdere bekende functies van J. Marc Simard
Bedrijven | Functie | Einde |
---|---|---|
Embark Healthcare
![]() Embark Healthcare Investment ManagersFinance Embark Healthcare (Embark Healthcare) is a ventures capital firm founded in 2001 by David M Geliebter. The firm is headquartered in New York. | Corporate Officer/Principal | - |
Opleiding van J. Marc Simard
St. Anselm College | Undergraduate Degree |
Creighton University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Embark Healthcare
![]() Embark Healthcare Investment ManagersFinance Embark Healthcare (Embark Healthcare) is a ventures capital firm founded in 2001 by David M Geliebter. The firm is headquartered in New York. | Finance |
Remedy Pharmaceuticals, Inc.
![]() Remedy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Remedy Pharmaceuticals, Inc. develops and commercializes pharmaceutical ingridients. It focuses on small molecule drugs for acute central nervous system disorders. The company was founded by David M. Geliebter and Sven M. Jacobson in 2004 and is headquartered in New York, NY. | Health Technology |